Basel, Switzerland
MIAC AG, established in 1995, originates as an academic initiative from the Basel University Hospital and has evolved into a prominent imaging Contract Research Organization (CRO) based in Switzerland. Renowned for its Swiss quality standards, it supports international clinical trials by translating advanced imaging and post-processing modalities from development to clinical applications.
The company delivers specialized image data analysis services with a team comprising board-certified neuro-radiologists, physicists, biomedical engineers, IT specialists, and clinicians. MIAC prides itself on providing tailored medical image analysis, emphasizing customer service and data safety, compliant with FDA – 21 CFR Part 11 and ICH – Good Clinical Practices.
With a focus on personalized service and committed to quality, MIAC plays a critical role in generating significant scientific outcomes for the pharmaceutical industry's international trials. No recent investments or investor activities have been reported.
